Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
Clinical trial NCT02684084 · TERMINATED
Trial details
- NCT number
- NCT02684084
- Sponsor
- North Toronto Eye Care Laser and Eye Specialists
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.